Inventor · disambiguated record
Debra L. Fleenor
Also filed as: FLEENOR DEBRA L
2 granted patents·23 pending applications·14 citations·filing 2002–2012
57Inventor score
Top patents by PatentIndex Score
25 records- 0178US7351407B2Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathiesALCON INC·Filed 2003·Granted Apr 1, 2008·13 cites·11 claims
- 0270US7803824B2Use of inhibitors of Jun N-terminal kinases to treat glaucomaALCON INC·Filed 2006·Granted Sep 28, 2010·1 cites·3 claims
- 0366US2007142376A1Control of intraocular pressure using alk5 modulation agentsALCON INC·Filed 2006·Application pending·0 cites
- 0464US2008057072A1Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disordersALCON MFG LTD·Filed 2007·Application pending·0 cites
- 0559US2010120851A1Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucomaALCON RES LTD·Filed 2009·Application pending·0 cites
- 0658US2012115870A1Control of intraocular pressure using alk5 modulation agentsFLEENOR DEBRA L·Filed 2012·Application pending·0 cites
- 0758US2011160210A1Control of intraocular pressure using alk5 modulation agentsALCON INC·Filed 2011·Application pending·0 cites
- 0857US2009202524A1Pai-1 expression and activity inhibitors for the treatment of ocular disordersALCON RES LTD·Filed 2009·Application pending·0 cites
- 0956US2008176964A1Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathiesALCON RES LTD·Filed 2008·Application pending·0 cites
- 1053US2008107644A1Pai-1 binding modulators for the treatment of ocular disordersALCON MFG LTD·Filed 2007·Application pending·0 cites
- 1152US2007232675A1Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucomaALCON MFG LTD·Filed 2007·Application pending·0 cites
- 1251US2008025973A1Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disordersALCON MFG LTD·Filed 2007·Application pending·0 cites
- 1350US2010247548A1Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disordersALCON RES LTD·Filed 2010·Application pending·0 cites
- 1447US2005239871A1Statins for the treatment of ocular hypertension and glaucomaALCON INC·Filed 2005·Application pending·0 cites
- 1546US2012004274A1Use of inhibitors of jun n-terminal kinases to treat glaucomaFLEENOR DEBRA L·Filed 2011·Application pending·0 cites
- 1645US2011092523A1Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathiesALCON RES LTD·Filed 2010·Application pending·0 cites
- 1745US2008153903A1Inhibitors of protein kinase c-delta for the treatment of glaucomaALCON MFG LTD·Filed 2007·Application pending·0 cites
- 1845US2010311716A1Use of inhibitors of jun n-terminal kinases to treat glaucomaALCON INC·Filed 2010·Application pending·0 cites
- 1944US2012108632A1Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucomaSHEPARD ALLAN R·Filed 2012·Application pending·0 cites
- 2043US2011105574A1Pai-1 expression and activity inhibitors for the treatment of ocular disordersALCON RES LTD·Filed 2011·Application pending·0 cites
- 2142US2011098314A1Statins for the treatment of ocular hypertension and glaucomaALCON INC·Filed 2010·Application pending·0 cites
- 2242US2004110776A1Use of propentofylline to control intraocular pressureFiled 2002·Application pending·0 cites
- 2341US2010260784A1Pai-1 binding modulators for the treatment of ocular disordersALCON RES LTD·Filed 2010·Application pending·0 cites
- 2439US2010183629A1Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disordersALCON RES LTD·Filed 2010·Application pending·0 cites
- 2530US2010158897A1Pai-1 modulators for the treatment of ocular disordersALCON RES LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Debra L. Fleenor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →